The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of gemcitabine + cisplatin + ipilimumab in patients with metastatic urothelial cancer.
 
Matt D. Galsky
Stock and Other Ownership Interests - Dual Therapeutics
Consulting or Advisory Role - Astellas Pharma; BioMotiv; Dendreon; GlaxoSmithKline; Janssen; Lilly; Merck
Research Funding - Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
Travel, Accommodations, Expenses - Astellas Pharma; BioMotiv; Dendreon; Merck
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Medivation; Merck; Oncogenex
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Costantine Albany
No Relationships to Disclose
 
Mark T. Fleming
No Relationships to Disclose
 
Alexander Starodub
No Relationships to Disclose
 
Przemyslaw Twardowski
No Relationships to Disclose
 
Sumanta K. Pal
No Relationships to Disclose
 
Ralph J. Hauke
Honoraria - Best Doctors, Inc
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); US Oncology (Inst)
Other Relationship - ABIM Subspecialty Board
 
Guru Sonpavde
Consulting or Advisory Role - Bayer; Genentech; GlaxoSmithKline; Merck; Sanofi
Research Funding - Onyx (Inst)
 
William K. Oh
Honoraria - Amgen; Astellas Pharma; Bayer; Bellicum Pharmaceuticals; Dendreon; Janssen Biotech; Pfizer; Sanofi
 
Nina Bhardwaj
No Relationships to Disclose
 
Sacha Gnjatic
No Relationships to Disclose
 
Seunghee Kim-Schulze
No Relationships to Disclose
 
Ziyue Liu
No Relationships to Disclose